134 related articles for article (PubMed ID: 34972058)
1. Role of MRI in characterizing serous borderline ovarian tumor and its subtypes: Correlation of MRI features with clinicopathological characteristics.
Li K; Song F; Yu L; Shi H; Wang J; Cheng X
Eur J Radiol; 2022 Feb; 147():110112. PubMed ID: 34972058
[TBL] [Abstract][Full Text] [Related]
2. Are CT and MRI useful tools to distinguish between micropapillary type and typical type of ovarian serous borderline tumors?
Zhang Y; Tan J; Wang J; Ai C; Jin Y; Wang H; Li M; Zhang H; Zhong S
Abdom Radiol (NY); 2021 Jul; 46(7):3354-3364. PubMed ID: 33660041
[TBL] [Abstract][Full Text] [Related]
3. Micropapillary pattern in serous borderline ovarian tumors: does it matter?
Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
Gynecol Oncol; 2011 Dec; 123(3):511-6. PubMed ID: 21917305
[TBL] [Abstract][Full Text] [Related]
4. MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation.
Nakai G; Yamada T; Yamamoto K; Hirose Y; Ohmichi M; Narumi Y
J Ovarian Res; 2018 Jan; 11(1):7. PubMed ID: 29321056
[TBL] [Abstract][Full Text] [Related]
5. Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary.
Uzan C; Kane A; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
Oncologist; 2011; 16(2):189-96. PubMed ID: 21273510
[TBL] [Abstract][Full Text] [Related]
6. MRI appearances of ovarian serous borderline tumor: pathological correlation.
Zhao SH; Qiang JW; Zhang GF; Boyko OB; Wang SJ; Cai SQ; Wang L
J Magn Reson Imaging; 2014 Jul; 40(1):151-6. PubMed ID: 24923479
[TBL] [Abstract][Full Text] [Related]
7. MRI appearances of pure epithelial papillary serous borderline ovarian tumours.
Naqvi J; Nagaraju E; Ahmad S
Clin Radiol; 2015 Apr; 70(4):424-32. PubMed ID: 25515794
[TBL] [Abstract][Full Text] [Related]
8. Advanced stage micropapillary serous borderline ovarian tumor in a postmenopausal woman: a case report.
Güngör T; Kaba M; Başer E; Yalçın H; Bayramoğlu H; Beşli M
J Turk Ger Gynecol Assoc; 2012; 13(3):208-11. PubMed ID: 24592040
[TBL] [Abstract][Full Text] [Related]
9. Ovarian serous surface papillary borderline tumor: characteristic imaging features with clinicopathological correlation.
Park SB; Kim MJ; Lee KH; Ko Y
Br J Radiol; 2018 Jul; 91(1088):20170689. PubMed ID: 29888983
[TBL] [Abstract][Full Text] [Related]
10. Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors.
Akçay A; Peker AA; Oran Z; Toprak H; Toluk Ö; Balsak S; Badur BA; Gültekin MA
Abdom Radiol (NY); 2024 Jan; 49(1):229-236. PubMed ID: 37857912
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic extended usefulness of RMI: comparison of four risk of malignancy index in preoperative differentiation of borderline ovarian tumors and benign ovarian tumors.
Zhang S; Yu S; Hou W; Li X; Ning C; Wu Y; Zhang F; Jiao YF; Lee LTO; Sun L
J Ovarian Res; 2019 Sep; 12(1):87. PubMed ID: 31526390
[TBL] [Abstract][Full Text] [Related]
12. Perfusion-based functional magnetic resonance imaging for differentiating serous borderline ovarian tumors from early serous ovarian cancers in a rat model.
Cai SQ; Li Y; Li YA; Wang L; Zhu J; Zhao SH; Qiang JW
Acta Radiol; 2021 Jan; 62(1):129-138. PubMed ID: 32276553
[TBL] [Abstract][Full Text] [Related]
13. Serous borderline ovarian tumours: an extensive review on MR imaging features.
Sahin H; Akdogan AI; Smith J; Zawaideh JP; Addley H
Br J Radiol; 2021 Sep; 94(1125):20210116. PubMed ID: 34111956
[TBL] [Abstract][Full Text] [Related]
14. Behavior of serous borderline ovarian tumors with and without micropapillary patterns: results of a French multicenter study.
Fauvet R; Demblocque E; Morice P; Querleu D; Daraï E
Ann Surg Oncol; 2012 Mar; 19(3):941-7. PubMed ID: 21879267
[TBL] [Abstract][Full Text] [Related]
15. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
[TBL] [Abstract][Full Text] [Related]
16. Is MRI a useful tool to distinguish between serous and mucinous borderline ovarian tumours?
Bazot M; Haouy D; Daraï E; Cortez A; Dechoux-Vodovar S; Thomassin-Naggara I
Clin Radiol; 2013 Jan; 68(1):e1-8. PubMed ID: 23044365
[TBL] [Abstract][Full Text] [Related]
17. K-ras mutations in Müllerian inclusion cysts associated with serous borderline tumors of the ovary.
Alvarez AA; Moore WF; Robboy SJ; Bentley RC; Gumbs C; Futreal PA; Berchuck A
Gynecol Oncol; 2001 Feb; 80(2):201-6. PubMed ID: 11161860
[TBL] [Abstract][Full Text] [Related]
18. A rat model of serous borderline ovarian tumors induced by 7,12-dimethylbenz[a]anthracene.
Cai SQ; Li Y; Li YA; Wang L; Zhu J; Zhao SH; Li X; Qiang JW
Exp Anim; 2019 Aug; 68(3):257-265. PubMed ID: 30760660
[TBL] [Abstract][Full Text] [Related]
19. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I; Darb-Esfahani S; Sehouli J
BJOG; 2016 Mar; 123(4):498-508. PubMed ID: 26705090
[TBL] [Abstract][Full Text] [Related]
20. Clinical Predictors of Recurrence and Prognostic Value of Lymph Node Involvement in the Serous Borderline Ovarian Tumor.
Qian XQ; Hua XP; Wu JH; Shen YM; Cheng XD; Wan XY
Int J Gynecol Cancer; 2018 Feb; 28(2):279-284. PubMed ID: 29194193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
